Found: 33
Select item for more details and to access through your institution.
Is it 'gene therapy'?
- Published in:
- Journal of Law & the Biosciences, 2018, v. 5, n. 3, p. 786, doi. 10.1093/jlb/lsy020
- By:
- Publication type:
- Article
Patent protection for CRISPR: an ELSI review.
- Published in:
- Journal of Law & the Biosciences, 2017, v. 4, n. 3, p. 565, doi. 10.1093/jlb/lsx036
- By:
- Publication type:
- Article
Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.66274
- By:
- Publication type:
- Article
Inferred Allelic Variants of Immunoglobulin Receptor Genes: A System for Their Evaluation, Documentation, and Naming.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00435
- By:
- Publication type:
- Article
REGULATORY SANDBOXES AND THE PUBLIC HEALTH.
- Published in:
- University of Illinois Law Review, 2022, v. 2022, n. 1, p. 357
- By:
- Publication type:
- Article
The Natural Complexity of Patent Eligibility.
- Published in:
- Iowa Law Review, 2014, v. 99, n. 3, p. 1137
- By:
- Publication type:
- Article
The rise of the ethical license.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 1, p. 22, doi. 10.1038/nbt.3756
- By:
- Publication type:
- Article
Protecting products versus platforms.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 5, p. 462, doi. 10.1038/nbt.3553
- By:
- Publication type:
- Article
The changing life science patent landscape.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 3, p. 292, doi. 10.1038/nbt.3504
- By:
- Publication type:
- Article
Law, history and lessons in the CRISPR patent conflict.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 256, doi. 10.1038/nbt.3160
- By:
- Publication type:
- Article
CASE STUDY: Myriad stands alone.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 620, doi. 10.1038/nbt.2944
- By:
- Publication type:
- Article
Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 4, p. 316, doi. 10.1038/nbt.2542
- By:
- Publication type:
- Article
Patent Eligibility Reform and the Public Health.
- Published in:
- Milbank Quarterly, 2019, v. 97, n. 3, p. 654, doi. 10.1111/1468-0009.12408
- By:
- Publication type:
- Article
PATENT LAW’S REPRODUCIBILITY PARADOX.
- Published in:
- Duke Law Journal, 2017, v. 66, n. 4, p. 845
- By:
- Publication type:
- Article
Fortune and hindsight: gene patents' muted effect on medical practice.
- Published in:
- British Medical Bulletin, 2018, v. 126, n. 1, p. 37, doi. 10.1093/bmb/ldy009
- By:
- Publication type:
- Article
ADMINISTRATING PATENT LITIGATION.
- Published in:
- Washington Law Review, 2015, v. 90, n. 1, p. 205
- By:
- Publication type:
- Article
A CALL FOR THE END OF THE DOCTRINE OF REALIGNMENT.
- Published in:
- Michigan Law Review, 2008, v. 107, n. 3, p. 525
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Gene Editing Sperm and Eggs (not Embryos): Does it Make a Legal or Ethical Difference?
- Published in:
- Journal of Law, Medicine & Ethics, 2020, v. 48, n. 3, p. 619, doi. 10.1177/1073110520958891
- By:
- Publication type:
- Article
PATENT INFRINGEMENT AS CRIMINAL CONDUCT.
- Published in:
- Michigan Telecommunications & Technology Law Review, 2012, v. 19, n. 1, p. 1
- By:
- Publication type:
- Article
Inventive steps: the CRISPR patent dispute and scientific progress.
- Published in:
- EMBO Reports, 2017, v. 18, n. 7, p. 1047, doi. 10.15252/embr.201744418
- By:
- Publication type:
- Article
Negativing Invention.
- Published in:
- Brigham Young University Law Review, 2011, v. 2011, n. 4, p. 1091
- By:
- Publication type:
- Article
Regulating Direct-to-Consumer Polygenic Risk Scores.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 8, p. 691, doi. 10.1001/jama.2023.12262
- By:
- Publication type:
- Article
Assessing—and Extending—California's Insulin Manufacturing Initiative.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 7, p. 533, doi. 10.1001/jama.2023.0013
- By:
- Publication type:
- Article
Governing Human Germline Editing Through Patent Law.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 12, p. 1149, doi. 10.1001/jama.2021.13824
- By:
- Publication type:
- Article
Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic.
- Published in:
- Genome Medicine, 2017, v. 9, p. 1, doi. 10.1186/s13073-017-0475-4
- By:
- Publication type:
- Article
THE PICK-AND-SHOVEL PLAY: BIOETHICS FOR GENE-EDITING VECTOR PATENTS.
- Published in:
- North Carolina Law Review, 2019, v. 97, n. 5, p. 1497
- By:
- Publication type:
- Article
CANCER'S IP.
- Published in:
- North Carolina Law Review, 2018, v. 96, n. 2, p. 297
- By:
- Publication type:
- Article
The Antibody Patent Paradox.
- Published in:
- Yale Law Journal, 2023, v. 132, n. 4, p. 994
- By:
- Publication type:
- Article
The FDA De Novo medical device pathway, patents and anticompetition.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 9, p. 1028, doi. 10.1038/s41587-020-0653-6
- By:
- Publication type:
- Article
Handle with Care: The WHO Report on Human Genome Editing.
- Published in:
- Hastings Center Report, 2022, v. 52, n. 2, p. 10, doi. 10.1002/hast.1350
- By:
- Publication type:
- Article
23andMe, the Food and Drug Administration, and the Future of Genetic Testing.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 4, p. 493, doi. 10.1001/jamainternmed.2013.14706
- By:
- Publication type:
- Article
The Future of Gene Patents and the Implications for Medicine.
- Published in:
- JAMA Internal Medicine, 2013, v. 173, n. 17, p. 1569, doi. 10.1001/jamainternmed.2013.10153
- By:
- Publication type:
- Article